Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals 1 Year Total Returns (Daily) : 26.94% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 26.94% |
| August 20, 2026 | 32.54% |
| August 19, 2026 | 42.32% |
| August 18, 2026 | 33.96% |
| August 17, 2026 | 41.92% |
| August 14, 2026 | 36.67% |
| August 13, 2026 | 35.86% |
| August 12, 2026 | 49.36% |
| August 11, 2026 | 53.15% |
| August 10, 2026 | 49.06% |
| August 07, 2026 | 49.01% |
| August 06, 2026 | 50.94% |
| August 05, 2026 | 51.70% |
| August 04, 2026 | 62.62% |
| August 03, 2026 | 59.51% |
| July 31, 2026 | 54.48% |
| July 30, 2026 | 70.11% |
| July 29, 2026 | 85.76% |
| July 28, 2026 | 83.17% |
| July 27, 2026 | 84.74% |
| July 24, 2026 | 82.01% |
| July 23, 2026 | 77.13% |
| July 22, 2026 | 71.55% |
| July 21, 2026 | 65.22% |
| July 20, 2026 | 60.32% |
| Date | Value |
|---|---|
| July 17, 2026 | 58.71% |
| July 16, 2026 | 58.14% |
| July 15, 2026 | 76.85% |
| July 14, 2026 | 67.84% |
| July 13, 2026 | 68.33% |
| July 10, 2026 | 70.58% |
| July 09, 2026 | 81.47% |
| July 08, 2026 | 96.65% |
| July 07, 2026 | 88.59% |
| July 06, 2026 | 77.16% |
| July 02, 2026 | 75.95% |
| July 01, 2026 | 71.37% |
| June 30, 2026 | 77.42% |
| June 29, 2026 | 75.32% |
| June 26, 2026 | 71.16% |
| June 25, 2026 | 85.06% |
| June 24, 2026 | 78.88% |
| June 23, 2026 | 81.43% |
| June 22, 2026 | 79.50% |
| June 18, 2026 | 78.89% |
| June 17, 2026 | 78.78% |
| June 16, 2026 | 75.82% |
| June 15, 2026 | 69.08% |
| June 12, 2026 | 61.76% |
| June 11, 2026 | 61.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Insmed, Inc. | -5.15% |
| PTC Therapeutics, Inc. | 42.72% |
| Protagonist Therapeutics, Inc. | 175.4% |
| Exelixis, Inc. | 39.71% |
| Karyopharm Therapeutics, Inc. | -67.44% |